Evidence map›Paper›PMID 42784290›Full record

ArticleToxins2026

Non-Surgical Ear Rejuvenation Through Selective Neuromodulation with Onabotulinum and Abobotulinum Toxin-A.

Paola Rosalba Russo, Andrea Sbarbati, Emanuele Bartoletti, Loredana Cavalieri, Maurizio Cavallini, Valentina Pinto, Giovanni Salti, Sheila Veronese

Abstract read
In one paragraph

Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paola Rosalba RussoEstemed Clinic, 41122 Modena, Italy.
Andrea SbarbatiDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Emanuele BartolettiDepartment of Aesthetic Medicine, Gemelli Isola Tiberina Hospital, 00186 Rome, Italy.ORCID 0009-0003-2618-1903
Loredana CavalieriPlastic Reconstructive and Aesthetic Surgery Unit, Italian Society of Aesthetic Medicine, 00195 Rome, Italy.
Maurizio CavalliniClinical and Educational Center Agorà, 20122 Milan, Italy.
Valentina PintoDepartment of Plastic and Reconstructive Surgery, Modena University Hospital, 41124 Modena, Italy.ORCID 0000-0001-5705-397X
Giovanni SaltiMedlight Institute, 50144 Florence, Italy.ORCID 0000-0002-7336-154X
Sheila VeroneseDepartment of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-6707-3306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, there are no studies concerning the ear aging phases, nor adequate anti-aging protocols. The aims of this study are: (1) to propose an aesthetic classification of auricular aging; (2) to evaluate the aesthetic implications, efficacy, and safety levels of botulinum toxin application to the auricles as anti-aging treatment. A retrospective study was conducted in a single center on 40 patients' charts to define an aesthetic ear aging classification, focusing on the muscles involved in the aging process; then an analysis on the results of the treatment of 50 healthy women (50-65 years), with the botulinum toxin type A for ear rejuvenation was conducted; the technique, visual aesthetic results, incidence of side effects, and efficiency of the treatment were presented. All procedures were performed in 2024, and subjects were monitored for the duration of the effects. Auricle aging process may be classified into 4 degrees. The treatment of 50 women with aging ears degree 1-2 permits correction of both ear protrusion and shape. In 1.5% of the auricles, mild swelling and transient bruising at the injection site were observed immediately after the treatment and resolved within 2-3 days. Patient satisfaction was high, and two external reviewers confirmed the treatment's aesthetic efficiency. Aesthetic classification of auricle aging can be a useful tool in anti-aging decision-making. Ear treatment with botulinum toxin type A seems complementary to face treatment. The results are encouraging, but the number of subjects treated is limited. Further studies are required to outline age-related guidelines.

Indexed as

AgingBotulinum Toxins, Type AEar AuricleNeuromuscular AgentsRejuvenationAgedFemaleHumansMiddle AgedRetrospective StudiesabobotulinumtoxinABotulinum Toxins, Type ANeuromuscular Agentsonabotulinum toxin Aauricle agingauricle aging classificationauricle aging treatmentbotulinum toxin type Aear aging

Identifiers

PMID42784290
PMCPMC13611376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.